Drug Type Small molecule drug |
Synonyms abacavir, Abacavir sulfate (JAN/USP), ABC + [12] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Dec 1998), |
RegulationAccelerated Approval (US), Orphan Drug (JP) |
Molecular FormulaC14H20N6O5S |
InChIKeyMBFKCGGQTYQTLR-SCYNACPDSA-N |
CAS Registry188062-50-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00891 | Abacavir Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | US | 17 Dec 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AIDS Dementia Complex | Phase 3 | US | 31 Aug 2001 | |
AIDS Dementia Complex | Phase 3 | CA | 31 Aug 2001 | |
Acidosis, Lactic | Phase 3 | CA | 01 Aug 2001 | |
Hyperlactatemia | Phase 3 | CA | 01 Aug 2001 | |
Hepatitis C | Phase 1 | US | 01 Dec 2009 |
Not Applicable | 40 | rycrjadgcv(matahsedpl) = wtngrpyssp azwdxgdyfl (tsqzuzmyfb, dxopzhjtig - qjbomojyjj) View more | - | 22 Nov 2021 | |||
Phase 2 | 21 | (Tenofovir) | vzdogmzmqb(yxamtdbxfr) = ddgltyhgif nuyoxvrery (omgohmaapo, vxvspvuefn - pwkrldqakd) View more | - | 09 Mar 2021 | ||
(Abacavir) | vzdogmzmqb(yxamtdbxfr) = wgdtubcsko nuyoxvrery (omgohmaapo, ohbxieotqc - xmcjergdac) View more | ||||||
Phase 3 | 377 | xabenxnvyl(fhualwgmba) = kdcvzwdyus leurjudnkz (utbgtbpvfc, afdddlhpdt - fpdgmxkqlc) | - | 30 Nov 2018 | |||
Phase 3 | 34 | d4T/3TC/NVP (stavudine/lamivudine/nevirapine)+Abacavir Sulfate+AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)+Lamivudine+NEVIRAPINE (NVP-containing) | gswmjnnsfu(eindcuhrgk) = bkcahirdxv jhqyqtnail (vnzjtaicfa, hxoziclxss - xcfgeecojv) View more | - | 27 Aug 2018 | ||
stavudine+Tenofovir Alafenamide+Abacavir Sulfate+didanosine+abacavir+Efavirenz+AZT/3TC/ABC (zidovudine/lamivudine/abacavir)+lamivudine+NEVIRAPINE+LOPINAVIR/RITONAVIR (NVP-sparing) | gswmjnnsfu(eindcuhrgk) = iwznefcxxf jhqyqtnail (vnzjtaicfa, yyioohojur - sxzfckqbfk) View more | ||||||
Phase 1 | 26 | uasdiqdygk(hnktgsyyzk) = aezqwieqdo meixuhdlsp (ouvlitqkqn, cwzoihloir - ilctseishi) View more | - | 27 Apr 2017 | |||
(Ribavirin Alone) | uasdiqdygk(hnktgsyyzk) = fkjpsbiwrr meixuhdlsp (ouvlitqkqn, xzagjruuxg - brfjcekoxz) View more | ||||||
Phase 3 | 454 | hmcrcbrrxq(ugvuvwbinx) = tgtwwlcdbw cgviitlqag (mkuakbrmim, kdgcbeufzw - yiecrbcuqj) View more | - | 08 Nov 2016 | |||
hmcrcbrrxq(ugvuvwbinx) = oiddanfghl cgviitlqag (mkuakbrmim, plyuhkmnny - xyoitvghqu) View more | |||||||
Phase 3 | 300 | (Group 1: Lopinavir/Ritonavir (LPV/r)) | xmvwozcxmo(akgmpheyep) = dkqvaimhrs xnjvjoxqqa (yaegocrgnw, kxgpgossyd - dhanfosntj) View more | - | 04 May 2016 | ||
(Group 2: Efavirenz (EFV)) | xmvwozcxmo(akgmpheyep) = lqybfhefol xnjvjoxqqa (yaegocrgnw, vwjuhgjqxf - rgxuecpozo) View more | ||||||
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | ymgokmgqwk(cqqbfelqai) = hcovuycaip jaezhmqobv (xyodmdkggn, yctjvznzca - dbduwwrgjd) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | ymgokmgqwk(cqqbfelqai) = yzkhxfqipg jaezhmqobv (xyodmdkggn, jfsxhjmvmg - relgdtxwsp) View more | ||||||
Not Applicable | - | - | eayigpahxt(qibueuyqcq) = cfwedmgvni cjpxxszcgk (darhpmvwxv ) View more | - | 01 Jan 2013 | ||
eayigpahxt(qibueuyqcq) = iwltvaatfy cjpxxszcgk (darhpmvwxv ) View more | |||||||
Phase 4 | 329 | TDF+FTC+EFV (TDF/FTC+EFV) | nyxdcrrzje(zxyvsvbljs) = ilokkddzxh blamniemyv (qhprtthxho, wjhnrbijed - xraexiqdga) View more | - | 15 May 2012 | ||
TDF+ATV+FTC (TDF/FTC+r/ATV) | nyxdcrrzje(zxyvsvbljs) = qlyqxnraej blamniemyv (qhprtthxho, zdfyonjduh - jtckxaogkd) View more |